Vanda Pharmaceuticals (VNDA) FCF Margin (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported FCF Margin of 97.53% for Q1 2026, down 3042.0% on a YoY basis from 3.31% in Q1 2025, and down 89.03% sequentially from 51.59% in Q4 2025.
Vanda Pharmaceuticals (VNDA) FCF Margin (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 17 years of FCF Margin data on file, last reported at 97.53% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 3042.0% year-over-year to 97.53%; the trailing twelve-month figure through Mar 2026 stood at 58.45% (down 2995.0% YoY), and the FY2025 full-year result was 51.1%, down 4293.0% from the prior year.
- FCF Margin retreated to 97.53% in Q1 2026, from 51.59% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 50.8% in Q1 2023 to a low of 97.53% in Q1 2026.
- A 5-year average of 16.38% and a median of 8.8% in 2023 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin soared 4421 bps in 2023 and sank 8304 bps in 2025, its largest moves.
- Tracing VNDA's FCF Margin over 5 years: stood at 14.19% in 2022, then sank by 162 bps to 8.8% in 2023, then soared by 57 bps to 3.82% in 2024, then sank by 1251 bps to 51.59% in 2025, then plunged by 89 bps to 97.53% in 2026.
- Business Quant data shows VNDA's FCF Margin at 97.53% in Q1 2026, 51.59% in Q4 2025, and 56.5% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn | -97.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -97.53% |
| Dec 31, 2025 | -51.59% |
| Sep 30, 2025 | -56.50% |
| Jun 30, 2025 | -29.57% |
| Mar 31, 2025 | -67.11% |
| Dec 31, 2024 | -3.82% |
| Sep 30, 2024 | -30.94% |
| Jun 30, 2024 | -13.94% |
| Mar 31, 2024 | 15.93% |
| Dec 31, 2023 | -8.80% |
| Sep 30, 2023 | -5.34% |
| Jun 30, 2023 | -28.82% |
| Mar 31, 2023 | 50.80% |
| Dec 31, 2022 | 14.19% |
| Sep 30, 2022 | 19.43% |
| Jun 30, 2022 | 8.53% |
| Mar 31, 2022 | 6.60% |
| Dec 31, 2021 | 38.92% |
| Sep 30, 2021 | 13.42% |
| Jun 30, 2021 | 27.57% |